126 related articles for article (PubMed ID: 27916101)
1. [Increased serum levels of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients infected with Brucella].
Pang P; Zhu Y; Jia B; Yang Y; Hu J; Zhang Y; Zhang F; Ding J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1675-1678. PubMed ID: 27916101
[TBL] [Abstract][Full Text] [Related]
2. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
Yanaba K; Hayashi M; Yoshihara Y; Nakagawa H
J Dermatol; 2016 Aug; 43(8):954-7. PubMed ID: 26945563
[TBL] [Abstract][Full Text] [Related]
4. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
Luo L; Shu M; Li S; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
Takahashi N; Iwasa S; Sasaki Y; Shoji H; Honma Y; Takashima A; Okita NT; Kato K; Hamaguchi T; Yamada Y
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1727-38. PubMed ID: 27256004
[TBL] [Abstract][Full Text] [Related]
6. Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis.
Li Y; Xiao Y; Su M; Zhang R; Ding J; Hao X; Ma Y
Exp Ther Med; 2016 Jan; 11(1):251-256. PubMed ID: 26889250
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.
Wang L; Wang H; Chen H; Wang WD; Chen XQ; Geng QR; Xia ZJ; Lu Y
Oncotarget; 2015 Dec; 6(38):41228-36. PubMed ID: 26515600
[TBL] [Abstract][Full Text] [Related]
8. Circulating Th1, Th2, Th17, Treg, and PD-1 Levels in Patients with Brucellosis.
Zheng R; Xie S; Zhang Q; Cao L; Niyazi S; Lu X; Sun L; Zhou Y; Zhang Y; Wang K
J Immunol Res; 2019; 2019():3783209. PubMed ID: 31467933
[No Abstract] [Full Text] [Related]
9. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
Okuyama M; Mezawa H; Kawai T; Urashima M
Front Immunol; 2019; 10():86. PubMed ID: 30833943
[No Abstract] [Full Text] [Related]
10. Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.
Fukasawa T; Yoshizaki A; Ebata S; Nakamura K; Saigusa R; Miura S; Yamashita T; Hirabayashi M; Ichimura Y; Taniguchi T; Asano Y; Shimizu H; Kazoe Y; Mawatari K; Kitamori T; Sato S
Arthritis Rheumatol; 2017 Sep; 69(9):1879-1890. PubMed ID: 28556548
[TBL] [Abstract][Full Text] [Related]
11. Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients.
Nasiri Kalmarzi R; Fattahi N; Kaviani Z; Ataee P; Mansouri M; Moradi G; Yousefzade A; Abbassi JM
Allergol Int; 2017 Apr; 66(2):326-331. PubMed ID: 27617656
[TBL] [Abstract][Full Text] [Related]
12. [A study on the Th1/Th2 cytokines in the pathogenesis of human tuberculous pleuritis].
Li YH; Xie CM
Zhonghua Jie He He Hu Xi Za Zhi; 2004 May; 27(5):324-7. PubMed ID: 15196342
[TBL] [Abstract][Full Text] [Related]
13. Percentages of PD-1
Wang Y; Pang N; Wang X; Liu Y; Wang X; Wang L; Sun M; Yasen H; Zhao F; Fan W; Guo X; Ding J
Hum Vaccin Immunother; 2018 Apr; 14(4):832-838. PubMed ID: 29333980
[TBL] [Abstract][Full Text] [Related]
14. Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases.
Shi B; Du X; Wang Q; Chen Y; Zhang X
Metabolism; 2013 Jun; 62(6):778-85. PubMed ID: 23398844
[TBL] [Abstract][Full Text] [Related]
15. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.
Aarslev K; Dige A; Greisen SR; Kreutzfeldt M; Jessen N; Vilstrup H; Deleuran B; Grønbæk H
Scand J Gastroenterol; 2017 Jan; 52(1):93-99. PubMed ID: 27604386
[TBL] [Abstract][Full Text] [Related]
16. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic significance of Th1/Th2 cytokine pattern in childhood hemophagocytic lymphohistiocytosis].
Xu XJ; Tang YM; Zhao N; Song H; Yang SL; Shi SW; Xu WQ; Pan BH; Zhang LY; Mao JQ; Shen HP; Gu ME; Xia J
Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):685-9. PubMed ID: 22176904
[TBL] [Abstract][Full Text] [Related]
18. Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis.
Cai L; Zhang C; Wu J; Zhou W; Chen T
Clin Immunol; 2021 Aug; 229():108800. PubMed ID: 34289424
[TBL] [Abstract][Full Text] [Related]
19. The relationship between B7 homologous 1 with interleukin-4, interleukin-17 and interferon gamma in patients with allergic rhinitis.
Nasiri Kalmarzi R; Fakhimi R; Manouchehri F; Ataee P; Naleini N; Babaei E; Azadi N; Rabeti K; Kooti W
Expert Rev Clin Immunol; 2019 Aug; 15(8):897-901. PubMed ID: 31269820
[No Abstract] [Full Text] [Related]
20. [Research on different expressions of peripheral blood Th1/Th2 cells in psoriasis patients of blood heat syndrome and of blood stasis syndrome].
Chen J; Cao XX; Xu R; Li X; Li FL; Fan B; Wang YF; Li F; Li B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):46-50. PubMed ID: 24520787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
